These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11703395)

  • 1. Investigation of AM-36: a novel neuroprotective agent.
    Callaway JK
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):913-8. PubMed ID: 11703395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence.
    Callaway JK; Castillo-Melendez M; Giardina SF; Krstew EK; Beart PM; Jarrott B
    Neuropharmacology; 2004 Jul; 47(1):146-55. PubMed ID: 15165842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis.
    Callaway JK; Beart PM; Jarrott B; Giardina SF
    Br J Pharmacol; 2001 Apr; 132(8):1691-8. PubMed ID: 11309240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
    Callaway JK; Knight MJ; Watkins DJ; Beart PM; Jarrott B
    Stroke; 1999 Dec; 30(12):2704-12; discussion 2712. PubMed ID: 10583001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral ischemia-hypoxia and biophysical mechanisms of neurodegeneration and neuroprotection effects].
    Mahura IS
    Fiziol Zh (1994); 2003; 49(2):7-12. PubMed ID: 12945108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion.
    Callaway JK; Lawrence AJ; Jarrott B
    Neuropharmacology; 2003 May; 44(6):787-800. PubMed ID: 12681377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate.
    Goldin SM; Subbarao K; Sharma R; Knapp AG; Fischer JB; Daly D; Durant GJ; Reddy NL; Hu LY; Magar S
    Ann N Y Acad Sci; 1995 Sep; 765():210-29. PubMed ID: 7486608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.
    Brown CM; Calder C; Linton C; Small C; Kenny BA; Spedding M; Patmore L
    Br J Pharmacol; 1995 Aug; 115(8):1425-32. PubMed ID: 8564201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pre-ischaemic neuroprotective effect of a novel polyamine antagonist, N1-dansyl-spermine in a permanent focal cerebral ischaemia model in mice.
    Li J; Henman MC; Doyle KM; Strbian D; Kirby BP; Tatlisumak T; Shaw GG
    Brain Res; 2004 Dec; 1029(1):84-92. PubMed ID: 15533319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effect of Sanguisorbae radix against oxidative stress-induced brain damage: in vitro and in vivo.
    Nguyen TT; Cho SO; Ban JY; Kim JY; Ju HS; Koh SB; Song KS; Seong YH
    Biol Pharm Bull; 2008 Nov; 31(11):2028-35. PubMed ID: 18981568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with excitatory amino acid antagonist drugs.
    Muir KW; Lees KR
    Stroke; 1995 Mar; 26(3):503-13. PubMed ID: 7886734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
    Smith SE; Hodges H; Sowinski P; Man CM; Leach MJ; Sinden JD; Gray JA; Meldrum BS
    Neuroscience; 1997 Apr; 77(4):1123-35. PubMed ID: 9130792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
    Weiser T; Brenner M; Palluk R; Bechtel WD; Ceci A; Brambilla A; Ensinger HA; Sagrada A; Wienrich M
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1343-9. PubMed ID: 10336525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMS-204352: a potassium channel opener developed for the treatment of stroke.
    Jensen BS
    CNS Drug Rev; 2002; 8(4):353-60. PubMed ID: 12481191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil attenuates excitotoxic damage induced by membrane depolarization of cortical neurons exposed to veratridine.
    Akasofu S; Sawada K; Kosasa T; Hihara H; Ogura H; Akaike A
    Eur J Pharmacol; 2008 Jul; 588(2-3):189-97. PubMed ID: 18508044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs.
    Ashton D; Willems R; Wynants J; Van Reempts J; Marrannes R; Clincke G
    Brain Res; 1997 Jan; 745(1-2):210-21. PubMed ID: 9037412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BQ-869, a novel NMDA receptor antagonist, protects against excitotoxicity and attenuates cerebral ischemic injury in stroke.
    Yu G; Wu F; Wang ES
    Int J Clin Exp Pathol; 2015; 8(2):1213-25. PubMed ID: 25973006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92.
    Caputi L; Hainsworth AH; Lavaroni F; Leach MJ; McNaughton NC; Mercuri NB; Randall AD; Spadoni F; Swan JH; Stefani A
    Brain Res; 2001 Nov; 919(2):259-68. PubMed ID: 11701138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia.
    Lysko PG; Webb CL; Yue TL; Gu JL; Feuerstein G
    Stroke; 1994 Dec; 25(12):2476-82. PubMed ID: 7974592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.